4,038
Views
8
CrossRef citations to date
0
Altmetric
Review

Probiotics to improve the gut microbiome in premature infants: are we there yet?

&
Article: 2201160 | Received 23 Dec 2022, Accepted 06 Apr 2023, Published online: 30 Apr 2023

References

  • Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, Angenent LT, Ley RE. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci. 2011;108(S1):4578–27. doi:10.1073/pnas.1000081107.
  • Xiao L, Wang J, Zheng J, Li X, Zhao F. Deterministic transition of enterotypes shapes the infant gut microbiome at an early age. Genome Biol. 2021;22(1):243. doi:10.1186/s13059-021-02463-3.
  • Guittar J, Shade A, Litchman E. Trait-based community assembly and succession of the infant gut microbiome. Nat Commun. 2019;10(1):512. doi:10.1038/s41467-019-08377-w.
  • Stiemsma LT, Michels KB. The role of the microbiome in the developmental origins of health and disease. Pediatrics. 2018;141(4): e20172437. doi:10.1542/peds.2017-2437.
  • Korpela K, Blakstad EW, Moltu SJ, Strømmen K, Nakstad B, Rønnestad AE, Brække K, Iversen PO, Drevon CA, de Vos W. Intestinal microbiota development and gestational age in preterm neonates. Sci Rep. 2018;8(1):2453. doi:10.1038/s41598-018-20827-x.
  • La Rosa PS, Warner BB, Zhou Y, Weinstock GM, Sodergren E, Hall-Moore CM, Stevens HJ, Bennett WE, Shaikh N, Linneman LA, et al. Patterned progression of bacterial populations in the premature infant gut. Proc Natl Acad Sci USA. 2014;111(34):12522–12527. doi:10.1073/pnas.1409497111.
  • Rao C, Coyte KZ, Bainter W, Geha RS, Martin CR, Rakoff-Nahoum S. Multi-kingdom ecological drivers of microbiota assembly in preterm infants. Nature. 2021;591(7851):633–638. doi:10.1038/s41586-021-03241-8.
  • Grier A, Qiu X, Bandyopadhyay S, Holden-Wiltse J, Kessler HA, Gill AL, Hamilton B, Huyck H, Misra S, Mariani TJ, et al. Impact of prematurity and nutrition on the developing gut microbiome and preterm infant growth. Microbiome. 2017;5(1):158. doi:10.1186/s40168-017-0377-0.
  • Morrow AL, Lagomarcino AJ, Schibler KR, Taft DH, Yu Z, Wang B, Altaye M, Wagner M, Gevers D, Ward DV, et al. Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome. 2013;1(1):13. doi:10.1186/2049-2618-1-13.
  • Pammi M, Cope J, Tarr PI, Warner BB, Morrow AL, Mai V, Gregory KE, Kroll JS, McMurtry V, Ferris MJ, et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. Microbiome. 2017;5(1):31. doi:10.1186/s40168-017-0248-8.
  • Masi AC, Embleton ND, Lamb CA, Young G, Granger CL, Najera J, Smith DP, Hoffman KL, Petrosino JF, Bode L, et al. Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis. Gut. 2021;70(12):2273–2282. doi:10.1136/gutjnl-2020-322771.
  • Stewart CJ, Embleton ND, Marrs ECL, Smith DP, Nelson A, Abdulkadir B, Skeath T, Petrosino JF, Perry JD, Berrington JE, et al. Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease. Microbiome. 2016;4(1):67. doi:10.1186/s40168-016-0216-8.
  • Olm MR, Bhattacharya N, Crits-Christoph A, Firek BA, Baker R, Song YS, Morowitz MJ, Banfield JF. Necrotizing enterocolitis is preceded by increased gut bacterial replication, Klebsiella, and fimbriae-encoding bacteria. Sci Adv. 2019;5(12):eaax5727. doi:10.1126/sciadv.aax5727.
  • Madan JC, Salari RC, Saxena D, Davidson L, O’Toole GA, Moore JH, Sogin ML, Foster JA, Edwards WH, Palumbo P, et al. Gut microbial colonisation in premature neonates predicts neonatal sepsis. Arch Dis Child Fetal Neonatal Ed. 2012;97(6):F456–462. doi:10.1136/fetalneonatal-2011-301373.
  • Shaw AG, Sim K, Randell P, Cox MJ, McClure ZE, M-S L, Donaldson H, Langford PR, Cookson WOCM, Moffatt MF, et al. Late-onset bloodstream infection and perturbed maturation of the gastrointestinal microbiota in premature infants. PLoS One. 2015;10(7):e0132923. doi:10.1371/journal.pone.0132923.
  • Stewart CJ, Embleton ND, Marrs ECL, Smith DP, Fofanova T, Nelson A, Skeath T, Perry JD, Petrosino JF, Berrington JE, et al. Longitudinal development of the gut microbiome and metabolome in preterm neonates with late onset sepsis and healthy controls. Microbiome. 2017;5(1):75. doi:10.1186/s40168-017-0295-1.
  • Graspeuntner S, Waschina S, Künzel S, Twisselmann N, Rausch TK, Cloppenborg-Schmidt K, Zimmermann J, Viemann D, Herting E, Göpel W, et al. Gut dysbiosis with bacilli dominance and accumulation of fermentation products precedes late-onset sepsis in preterm infants. Clin Infect Dis. 2019;69(2):268–277. doi:10.1093/cid/ciy882.
  • Bresesti I, Salvatore S, Valetti G, Baj A, Giaroni C, Agosti M. The microbiota-gut axis in premature infants: physio-pathological implications. Cells. 2022;11(3):379. doi:10.3390/cells11030379.
  • Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514. doi:10.1038/nrgastro.2014.66.
  • Dermyshi E, Wang Y, Yan C, Hong W, Qiu G, Gong X, Zhang T. The “Golden Age” of probiotics: a systematic review and meta-analysis of randomized and observational studies in preterm infants. Neonatology. 2017;112(1):9–23. doi:10.1159/000454668.
  • van den Akker CHP, van Goudoever JB, Szajewska H, Embleton ND, Hojsak I, Reid D, Shamir R, ESPGHAN Working group for probiotics, prebiotics & committee on nutrition. probiotics for preterm infants: a strain-specific systematic review and network meta-analysis. J Pediatr Gastroenterol Nutr. 2018;67(1):103–122. doi:10.1097/MPG.0000000000001897.
  • Chi C, Li C, Buys N, Wang W, Yin C, Sun J. Effects of probiotics in preterm infants: a network meta-analysis. Pediatrics. 2021;147(1):e20200706. doi:10.1542/peds.2020-0706.
  • Beghetti I, Panizza D, Lenzi J, Gori D, Martini S, Corvaglia L, Aceti A. Probiotics for preventing necrotizing enterocolitis in preterm infants: a network meta-analysis. Nutrients. 2021;13(1):192. doi:10.3390/nu13010192.
  • Zhang W, Wang S, Xing Y, Wang H, Fu B, Long M, Cao J. Clinical efficacy of probiotics on feeding intolerance in preterm infants: a systematic review and meta-analysis. Transl Pediatr. 2022;11(2):229–238. doi:10.21037/tp-21-624.
  • Deshmukh M, Patole S. Prophylactic probiotic supplementation for preterm neonates—a systematic review and meta-analysis of nonrandomized studies. Adv Nutr. 2021;12(4):1411–1423. doi:10.1093/advances/nmaa164.
  • Morgan RL, Preidis GA, Kashyap PC, Weizman AV, Sadeghirad B, Probiotic M, Florez ID, Foroutan F, Shahid S, Zeraatkar D, et al. Probiotics reduce mortality and morbidity in preterm, low-birth-weight infants: a systematic review and network meta-analysis of randomized trials. Gastroenterology. 2020;159(2):467–480. doi:10.1053/j.gastro.2020.05.096.
  • van den Akker CHP, van Goudoever JB, Shamir R, Domellöf M, Embleton ND, Hojsak I, Lapillonne A, Mihatsch WA, Berni Canani R, Bronsky J, et al. Probiotics and preterm infants: a position paper by the European society for paediatric gastroenterology hepatology and nutrition committee on nutrition and the European society for paediatric gastroenterology hepatology and nutrition working group for probiotics and prebiotics. J Pediatr Gastroenterol Nutr. 2020;70(5):664–680. doi:10.1097/MPG.0000000000002655.
  • Pell LG, Loutet MG, Roth DE, Sherman PM. Arguments against routine administration of probiotics for NEC prevention. Curr Opin Pediatr. 2019;31(2):195–201. doi:10.1097/MOP.0000000000000730.
  • Athalye-Jape G, Patole S. Probiotics for preterm infants – time to end all controversies. Microb Biotechnol. 2019;12(2):249–253. doi:10.1111/1751-7915.13357.
  • Berrington JE, Zalewski S. The future of probiotics in the preterm infant. Early Hum Dev. 2019;135:75–81. doi:10.1016/j.earlhumdev.2019.05.008.
  • Poindexter B, James C, Hand I, Adams-Chapman I, Aucott SW, Puopolo KM, Goldsmith JP, Kaufman D, Martin C, Mowitz M. Use of probiotics in preterm infants. Pediatrics. 2021;147(6):e2021051485. doi:10.1542/peds.2021-051485.
  • Melville J, Moss T. The immune consequences of preterm birth. Front Neurosci. 2013;7:79. doi:10.3389/fnins.2013.00079.
  • Tissières P, Ochoda A, Dunn-Siegrist I, Drifte G, Morales M, Pfister R, Berner M, Pugin J, Jeyaseelan S. Innate immune deficiency of extremely premature neonates can be reversed by interferon-γ. PLoS One. 2012;7(3):e32863. doi:10.1371/journal.pone.0032863.
  • Yousuf EI, Carvalho M, Dizzell SE, Kim S, Gunn E, Twiss J, Giglia L, Stuart C, Hutton EK. Persistence of suspected probiotic organisms in preterm infant gut microbiota weeks after probiotic supplementation in the NICU. Front Microbiol. 2020;11:574137. doi:10.3389/fmicb.2020.574137.
  • van Best N, Trepels-Kottek S, Savelkoul P, Orlikowsky T, Hornef MW, Penders J. Influence of probiotic supplementation on the developing microbiota in human preterm neonates. Gut Microbes. 2020;12(1):1826747. doi:10.1080/19490976.2020.1826747.
  • Beck LC, Masi AC, Young GR, Vatanen T, Lamb CA, Smith R, Coxhead J, Butler A, Marsland BJ, Embleton ND, et al. Strain-specific impacts of probiotics are a significant driver of gut microbiome development in very preterm infants. Nat Microbiol. 2022;7(10):1525–1535. doi:10.1038/s41564-022-01213-w.
  • Samara J, Moossavi S, Alshaikh B, Ortega VA, Pettersen VK, Ferdous T, Hoops SL, Soraisham A, Vayalumkal J, Dersch-Mills D, et al. Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infants. Cell Host & Microbe. 2022;30(5):696–711.e5. doi:10.1016/j.chom.2022.04.005.
  • Hui Y, Smith B, Mortensen MS, Krych L, Sørensen SJ, Greisen G, Krogfelt KA, Nielsen DS. The effect of early probiotic exposure on the preterm infant gut microbiome development. Gut Microbes. 2021;13(1):1951113. doi:10.1080/19490976.2021.1951113.
  • Alcon-Giner C, Dalby MJ, Caim S, Ketskemety J, Shaw A, Sim K, Lawson MAE, Kiu R, Leclaire C, Chalklen L, et al. Microbiota supplementation with bifidobacterium and lactobacillus modifies the preterm infant gut microbiota and metabolome: an observational study. Cell Rep Med. 2020;1(5):100077. doi:10.1016/j.xcrm.2020.100077.
  • Abdulkadir B, Nelson A, Skeath T, Marrs ECL, Perry JD, Cummings SP, Embleton ND, Berrington JE, Stewart CJ. Routine use of probiotics in preterm infants: longitudinal impact on the microbiome and metabolome. Neonatology. 2016;109(4):239–247. doi:10.1159/000442936.
  • Watkins C, Murphy K, Dempsey EM, O’Shea CA, Murphy BP, O’Toole PW, Ross RP, Stanton C, Ryan CA. Dose-interval study of a dual probiotic in preterm infants. Arch Dis Child - Fetal Neonatal Ed. 2019;104(2):F159–64. doi:10.1136/archdischild-2017-313468.
  • Alshaikh B, Samara J, Moossavi S, Ferdous T, Soraisham A, Dersch-Mills D, Arrieta M-C, Amin H. Multi-strain probiotics for extremely preterm infants: a randomized controlled trial. Pediatr Res. 2022;92(6):1663–1670. doi:10.1038/s41390-022-02004-z.
  • Sprockett D, Fukami T, Relman DA. Role of priority effects in the early-life assembly of the gut microbiota. Nat Rev Gastroenterol Hepatol. 2018;15(4):197–205. doi:10.1038/nrgastro.2017.173.
  • Gilbert JA, Lynch SV. Community ecology as a framework for human microbiome research. Nat Med. 2019;25(6):884–889. doi:10.1038/s41591-019-0464-9.
  • Chang C-S, Kao C-Y. Current understanding of the gut microbiota shaping mechanisms. J Biomed Sci. 2019;26(1):59. doi:10.1186/s12929-019-0554-5.
  • Hillman ET, Lu H, Yao T, Nakatsu CH. Microbial ecology along the gastrointestinal tract. Microbes Environ. 2017;32(4):300–313. doi:10.1264/jsme2.ME17017.
  • Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–227. doi:10.1038/nature11053.
  • Azad M, Konya T, Persaud R, Guttman D, Chari R, Field C, Sears M, Mandhane P, Turvey S, Subbarao P, et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG Int J Obstet Gynaecol. 2016;123(6):983–993. doi:10.1111/1471-0528.13601.
  • Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci. 2010;107(26):11971–11975. doi:10.1073/pnas.1002601107.
  • Brooks B, Olm MR, Firek BA, Baker R, Thomas BC, Morowitz MJ, Banfield JF. Strain-resolved analysis of hospital rooms and infants reveals overlap between the human and room microbiome. Nat Commun. 2017;8(1):1814. doi:10.1038/s41467-017-02018-w.
  • Taft DH, Ambalavanan N, Schibler KR, Yu Z, Newburg DS, Ward DV, Morrow AL. Intestinal microbiota of preterm infants differ over time and between hospitals. Microbiome. 2014;2(1):36. doi:10.1186/2049-2618-2-36.
  • Chernikova DA, Madan JC, Housman ML, Zain-Ul-Abideen M, Lundgren SN, Morrison HG, Sogin ML, Williams SM, Moore JH, Karagas MR, et al. The premature infant gut microbiome during the first 6 weeks of life differs based on gestational maturity at birth. Pediatr Res. 2018;84(1):71–79. doi:10.1038/s41390-018-0022-z.
  • Cuna A, Morowitz MJ, Ahmed I, Umar S, Sampath V. Dynamics of the preterm gut microbiome in health and disease. Am J Physiol Gastrointest Liver Physiol. 2021;320(4):G411–9. doi:10.1152/ajpgi.00399.2020.
  • Shen W, Qiu W, Liu Y, Liao W, Ma Y, He Y, Wang Z, Zhou H. Postnatal age is strongly correlated with the early development of the gut microbiome in preterm infants. Transl Pediatr. 2021;10(9):2313–2324. doi:10.21037/tp-21-367.
  • Henderickx JGE, de Weerd H, Groot Jebbink LJ, van Zoeren-Grobben D, Hemels MAC, van Lingen RA, Knol J, Belzer C. The first fungi: mode of delivery determines early life fungal colonization in the intestine of preterm infants. Microbiome Res Rep. 2022;1:7. doi:10.20517/mrr.2021.03.
  • James SA, Phillips S, Telatin A, Baker D, Ansorge R, Clarke P, Hall LJ, Carding SR. Preterm infants harbour a rapidly changing mycobiota that includes candida pathobionts. J Fungi. 2020;6(4):273. doi:10.3390/jof6040273.
  • Schei K, Simpson MR, Avershina E, Rudi K, Øien T, Júlíusson PB, Underhill D, Salamati S, Ødegård RA. Early gut fungal and bacterial microbiota and childhood growth. Front Pediatr. 2020; 8 :572538. doi:10.3389/fped.2020.572538.
  • Amenyogbe N, Adu-Gyasi D, Enuameh Y, Asante KP, Konadu DG, Kaali S, Dosoo D, Panigrahi P, Kollmann TR, Mohn WW, et al. Bacterial and fungal gut community dynamics over the first 5 years of life in predominantly rural communities in ghana. Front Microbiol. 2021;12:664407. doi:10.3389/fmicb.2021.664407.
  • Fujimura KE, Sitarik AR, Havstad S, Lin DL, Levan S, Fadrosh D, Panzer AR, LaMere B, Rackaityte E, Lukacs NW, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med. 2016;22(10):1187–1191. doi:10.1038/nm.4176.
  • Wampach L, Heintz-Buschart A, Hogan A, Muller EEL, Narayanasamy S, Laczny CC, Hugerth LW, Bindl L, Bottu J, Andersson AF, et al. Colonization and succession within the human gut microbiome by archaea, bacteria, and microeukaryotes during the first year of life. Front Microbiol. 2017;8:738. doi:10.3389/fmicb.2017.00738.
  • Ward TL, Dominguez-Bello MG, Heisel T, Al-Ghalith G, Knights D, Gale CA, Lozupone C. Development of the human mycobiome over the first month of life and across body sites. mSystems. 2018;3(3). e00140–17. doi:10.1128/mSystems.00140-17.
  • Kaelin EA, Rodriguez C, Hall-Moore C, Hoffmann JA, Linneman LA, Ndao IM, Warner BB, Tarr PI, Holtz LR, Lim ES. Longitudinal gut virome analysis identifies specific viral signatures that precede necrotizing enterocolitis onset in preterm infants. Nat Microbiol. 2022;7(5):653–662. doi:10.1038/s41564-022-01096-x.
  • Neu J. Gastrointestinal development and meeting the nutritional needs of premature infants. Am J Clin Nutr. 2007;85(2):629S–634S. doi:10.1093/ajcn/85.2.629S.
  • Splichalova A, Slavikova V, Splichalova Z, Splichal I. Preterm life in sterile conditions: a study on preterm, germ-free piglets. Front Immunol. 2018;9:220. doi:10.3389/fimmu.2018.00220.
  • Hackam DJ, Upperman JS, Grishin A, Ford HR. Disordered enterocyte signaling and intestinal barrier dysfunction in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg. 2005;14(1):49–57. doi:10.1053/j.sempedsurg.2004.10.025.
  • Heida FH, Beyduz G, Bulthuis MLC, Kooi EMW, Bos AF, Timmer A, Hulscher JBF. Paneth cells in the developing gut: when do they arise and when are they immune competent? Pediatr Res. 2016;80(2):306–310. doi:10.1038/pr.2016.67.
  • Liu Z, Li N, Neu J. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr. 2005;94(4):386–393. doi:10.1111/j.1651-2227.2005.tb01904.x.
  • Arboleya S, Solís G, Fernández N, de Los Reyes-Gavilán CG, Gueimonde M. Facultative to strict anaerobes ratio in the preterm infant microbiota. Gut Microbes. 2012;3(6):583–588. doi:10.4161/gmic.21942.
  • Lucas A, Bloom SR, Aynsley-Green A. Gut hormones and ‘minimal enteral feeding’. Acta Paediatr Scand. 1986;75(5):719–723. doi:10.1111/j.1651-2227.1986.tb10280.x.
  • Kennedy KA, Tyson JE, Chamnanvanikij S. 2000 Early versus delayed initiation of progressive enteral feedings for parenterally fed low birth weight or preterm infants. Cochrane Database Syst Rev. 2000;1:CD001970. doi:10.1002/14651858.CD001970.
  • Bochennek K, Fryns E, Wittekindt B, Buxmann H, Quaiser A, Fischer D, Klingebiel T, Koehl U, Schloesser R, Huenecke S. Immune cell subsets at birth may help to predict risk of late-onset sepsis and necrotizing enterocolitis in preterm infants. Early Hum Dev. 2016;93:9–16. doi:10.1016/j.earlhumdev.2015.10.018.
  • Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, Gustafsson A, Bernhardsson AK, Zhang C, Bohlin K, et al. Stereotypic immune system development in newborn children. Cell. 2018;174(5):1277–1292.e14. doi:10.1016/j.cell.2018.06.045.
  • Razak A, Patel RM, Gautham KS. Use of probiotics to prevent necrotizing enterocolitis: evidence to clinical practice. JAMA Pediatr. 2021;175(8):773–774. doi:10.1001/jamapediatrics.2021.1077.
  • Athalye-Jape G, Esvaran M, Patole S, Simmer K, Nathan E, Doherty D, Keil A, Rao S, Chen L, Chandrasekaran L, et al. Effect of single versus multistrain probiotic in extremely preterm infants: a randomised trial. BMJ Open Gastroenterol. 2022;9(1):e000811. doi:10.1136/bmjgast-2021-000811.
  • Chi C, Fan Y, Li C, Li Y, Guo S, Li T, Buys N, Clifton VL, Colditz PB, Yin C, et al. Early gut microbiota colonisation of premature infants fed with breastmilk or formula with or without probiotics: a cohort study. Nutrients. 2021;13(11):4068. doi:10.3390/nu13114068.
  • Fleming P, Wilks M, Eaton S, Panton N, Hutchinson R, Akyempon A, Hardy P, Millar MR, Costeloe K. Bifidobacterium breve BBG-001 and intestinal barrier function in preterm babies: exploratory studies from the PiPS trial. Pediatr Res. 2021;89(7):1818–1824. doi:10.1038/s41390-020-01135-5.
  • Hays S, Jacquot A, Gauthier H, Kempf C, Beissel A, Pidoux O, Jumas-Bilak E, Decullier E, Lachambre E, Beck L, et al. Probiotics and growth in preterm infants: a randomized controlled trial, PREMAPRO study. Clin Nutr Edinb Scotl. 2016;35(4):802–811. doi:10.1016/j.clnu.2015.06.006.
  • Millar M, Seale J, Greenland M, Hardy P, Juszczak E, Wilks M, Panton N, Costeloe K, Wade WG. The microbiome of infants recruited to a randomised placebo-controlled probiotic trial (PiPS Trial). EBioMedicine. 2017;20:255–262. doi:10.1016/j.ebiom.2017.05.019.
  • Underwood MA, Kalanetra KM, Bokulich NA, Lewis ZT, Mirmiran M, Tancredi DJ, Mills DA. A comparison of two probiotic strains of bifidobacteria in premature infants. J Pediatr. 2013;163(6):1585–1591.e9. doi:10.1016/j.jpeds.2013.07.017.
  • Martí M, Spreckels JE, Ranasinghe PD, Wejryd E, Marchini G, Sverremark-Ekström E, Jenmalm MC, Abrahamsson T. Effects of Lactobacillus reuteri supplementation on the gut microbiota in extremely preterm infants in a randomized placebo-controlled trial. Cell Rep Med. 2021;2(3):100206. doi:10.1016/j.xcrm.2021.100206.
  • Chang C-M, Tsai M-H, Liao W-C, Yang P-H, S-W L, Chu S-M, Huang H-R, Chiang M-C, Hsu J-F. Effects of probiotics on gut microbiomes of extremely preterm infants in the neonatal intensive care unit: a prospective cohort study. Nutrients. 2022;14(15):3239. doi:10.3390/nu14153239.
  • Gong C, Yang L, Liu K, Shen S, Zhang Q, Li H, Cheng Y. Effects of antibiotic treatment and probiotics on the gut microbiome of 40 infants delivered before term by cesarean section analysed by using 16s rRNA quantitative polymerase chain reaction sequencing. Med Sci Monit Int Med J Exp Clin Res. 2021;27:e928467. doi:10.12659/MSM.928467.
  • Kurath-Koller S, Neumann C, Moissl-Eichinger C, Kraschl R, Kanduth C, Hopfer B, Pausan M-R, Urlesberger B, Resch B. Hospital regimens including probiotics guide the individual development of the gut microbiome of very low birth weight infants in the first two weeks of life. Nutrients. 2020;12(5):1256. doi:10.3390/nu12051256.
  • Larke JA, Kuhn-Riordon K, Taft DH, Sohn K, Iqbal S, Underwood MA, Mills DA, Slupsky CM. Preterm infant fecal microbiota and metabolite profiles are modulated in a probiotic specific manner. J Pediatr Gastroenterol Nutr. 2022;75(4):535–542. doi:10.1097/MPG.0000000000003570.
  • Moreno-Sanz B, Montes MT, Manzano S, Espinosa-Martos I, Cárdenas N, Esteban S, Cruz M, Jiménez E, de Pipaón MS. Randomized,double-blind, placebo-controlled study to assess the effect of two probiotics on the preterms’ gut microbiota. J Pediatr Gastroenterol Nutr. 2022;74(6):e153–9. doi:10.1097/MPG.0000000000003427.
  • Plummer EL, Bulach DM, Murray GL, Jacobs SE, Tabrizi SN, Garland SM. ProPrems study group.Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial. BMC Microbiol. 2018;18(1):184. doi:10.1186/s12866-018-1326-1.
  • Qiao L-X, Zhu W-Y, Zhang H-Y, Wang H. Effect of early administration of probiotics on gut microflora and feeding in pre-term infants: a randomized controlled trial. J Matern Fetal Neonatal Med. 2017;30(1):13–16. doi:10.3109/14767058.2016.1163674.
  • Underwood MA, Salzman NH, Bennett SH, Barman M, Mills D, Marcobal A, Tancredi DJ, Bevins CL, Sherman MP. A randomized placebo-controlled comparison of two prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short chain fatty acids. J Pediatr Gastroenterol Nutr. 2009;48(2):216–225. doi:10.1097/MPG.0b013e31818de195.
  • Westaway JAF, Huerlimann R, Kandasamy Y, Miller CM, Norton R, Staunton KM, Watson D, Rudd D. The bacterial gut microbiome of probiotic-treated very-preterm infants: changes from admission to discharge. Pediatr Res. 2022;92(1):142–150. doi:10.1038/s41390-021-01738-6.
  • Westaway JAF, Huerlimann R, Kandasamy Y, Miller CM, Norton R, Watson D, Infante-Vilamil S, Rudd D. Exploring the long-term colonisation and persistence of probiotic-prophylaxis species on the gut microbiome of preterm infants: a pilot study. Eur J Pediatr. 2022;181(9):3389–3400. doi:10.1007/s00431-022-04548-y.
  • Westaway JAF, Huerlimann R, Kandasamy Y, Miller CM, Norton R, Watson D, Infante-Vilamil S, Rudd D. To probiotic or not to probiotic: a metagenomic comparison of the discharge gut microbiome of infants supplemented with probiotics in nicu and those who are not. Front Pediatr. 2022;10:838559. doi:10.3389/fped.2022.838559.
  • Costalos C, Skouteri V, Gounaris A, Sevastiadou S, Triandafilidou A, Ekonomidou C, Kontaxaki F, Petrochilou V. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev. 2003;74(2):89–96. doi:10.1016/s0378-3782(03)00090-2.
  • Zeber-Lubecka N, Kulecka M, Ambrozkiewicz F, Paziewska A, Lechowicz M, Konopka E, Majewska U, Borszewska-Kornacka M, Mikula M, Cukrowska B, et al. Effect of saccharomyces boulardii and mode of delivery on the early development of the gut microbial community in preterm infants. PLoS One. 2016;11(2):e0150306. doi:10.1371/journal.pone.0150306.
  • O’Callaghan A, van Sinderen D. Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol. 2016;7:925. doi:10.3389/fmicb.2016.00925.
  • Lawson MAE, O’Neill IJ, Kujawska M, Gowrinadh Javvadi S, Wijeyesekera A, Flegg Z, Chalklen L, Hall LJ. Breast milk-derived human milk oligosaccharides promote Bifidobacterium interactions within a single ecosystem. Isme J. 2020;14(2):635–648. doi:10.1038/s41396-019-0553-2.
  • Trosvik P, de Muinck EJ. Ecology of bacteria in the human gastrointestinal tract—identification of keystone and foundation taxa. Microbiome. 2015;3(1):44. doi:10.1186/s40168-015-0107-4.
  • Yasmin F, Tun HM, Konya TB, Guttman DS, Chari RS, Field CJ, Becker AB, Mandhane PJ, Turvey SE, Subbarao P, et al. Cesarean section, formula feeding, and infant antibiotic exposure: separate and combined impacts on gut microbial changes in later infancy. Front Pediatr. 2017;5:200. doi:10.3389/fped.2017.00200.
  • Garrido D, Ruiz-Moyano S, Lemay DG, Sela DA, German JB, Mills DA. Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria. Sci Rep. 2015;5(1):13517. doi:10.1038/srep13517.
  • Thongaram T, Hoeflinger JL, Chow J, Miller MJ. Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli. J Dairy Sci. 2017;100(10):7823–7833. doi:10.3168/jds.2017-12753.
  • Gotoh A, Katoh T, Sakanaka M, Ling Y, Yamada C, Asakuma S, Urashima T, Tomabechi Y, Katayama-Ikegami A, Kurihara S, et al. Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum. Sci Rep. 2018;8(1):13958. doi:10.1038/s41598-018-32080-3.
  • Walsh C, Lane JA, van Sinderen D, Hickey RM. Human milk oligosaccharide-sharing by a consortium of infant derived Bifidobacterium species. Sci Rep. 2022;12(1):4143. doi:10.1038/s41598-022-07904-y.
  • Pokusaeva K, Fitzgerald GF, van Sinderen D. Carbohydrate metabolism in Bifidobacteria. Genes Nutr. 2011;6(3):285–306. doi:10.1007/s12263-010-0206-6.
  • Fukuda S, Toh H, Taylor TD, Ohno H, Hattori M. Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters. Gut Microbes. 2012;3(5):449–454. doi:10.4161/gmic.21214.
  • Rezac S, Kok CR, Heermann M, Hutkins R. Fermented foods as a dietary source of live organisms. Front Microbiol. 2018;9:1785. doi:10.3389/fmicb.2018.01785.
  • Chu DM, Ma J, Prince AL, Antony KM, Seferovic MD, Aagaard KM. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat Med. 2017;23(3):314–326. doi:10.1038/nm.4272.
  • Di Cerbo A, Palmieri B, Aponte M, Morales-Medina JC, Iannitti T. Mechanisms and therapeutic effectiveness of lactobacilli. J Clin Pathol. 2016;69(3):187–203. doi:10.1136/jclinpath-2015-202976.
  • Collado MC, Meriluoto J, Salminen S. In vitro analysis of probiotic strain combinations to inhibit pathogen adhesion to human intestinal mucus. Food Res Int. 2007;40(5):629–636. doi:10.1016/j.foodres.2006.11.007.
  • Zheng J, Wittouck S, Salvetti E, Franz CMAP, Harris HMB, Mattarelli P, O’Toole PW, Pot B, Vandamme P, Walter J, et al. A taxonomic note on the genus lactobacillus: description of 23 novel genera, emended description of the genus lactobacillus beijerinck 1901, and union of lactobacillaceae and leuconostocaceae. Int J Syst Evol Microbiol. 2020;70(4):2782–2858. doi:10.1099/ijsem.0.004107.
  • Uriot O, Denis S, Junjua M, Roussel Y, Dary-Mourot A, Blanquet-Diot S. Streptococcus thermophilus: from yogurt starter to a new promising probiotic candidate? J Funct Foods. 2017;37:74–89. doi:10.1016/j.jff.2017.07.038.
  • İ̇spirli H, Demirbaş F, Dertli E. Characterization of functional properties of Enterococcus faecium strains isolated from human gut. Can J Microbiol. 2015;61(11):861–870. doi:10.1139/cjm-2015-0446.
  • McFarland LV. Systematic review and meta-analysis of saccharomyces boulardii in adult patients. World J Gastroenterol. 2010;16(18):2202–2222. doi:10.3748/wjg.v16.i18.2202.
  • Szajewska H, Kołodziej M. Systematic review with meta-analysis: saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Alimentary Pharmacology & Therapeutics. 2015;42(7):793–801. doi:10.1111/apt.13344.
  • Cayzeele-Decherf A, Pélerin F, Leuillet S, Douillard B, Housez B, Cazaubiel M, Jacobson GK, Jüsten P, Desreumaux P. Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: an individual subject meta-analysis. World J Gastroenterol. 2017;23(2):336–344. doi:10.3748/wjg.v23.i2.336.
  • Li Z, Zhu G, Li C, Lai H, Liu X, Zhang L. Which probiotic is the most effective for treating acute diarrhea in children? A bayesian network meta-analysis of randomized controlled trials. Nutrients. 2021;13(12):4319. doi:10.3390/nu13124319.
  • Kelesidis T, Pothoulakis C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Ther Adv Gastroenterol. 2012;5(2):111–125. doi:10.1177/1756283X11428502.
  • Sen S, Mansell TJ. Yeasts as probiotics: mechanisms, outcomes, and future potential. Fungal Genet Biol. 2020;137:103333. doi:10.1016/j.fgb.2020.103333.
  • Zhang F, Aschenbrenner D, Yoo JY, Zuo T. The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly. Lancet Microbe. 2022;3(12):e969–83. doi:10.1016/S2666-5247(22)00203-8.
  • Tiago FCP, Martins FS, Souza ELS, Pimenta PFP, Araujo HRC, Castro IM, Brandão RL, Nicoli JR. Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by saccharomyces probiotics. J Med Microbiol. 2012;61(9):1194–1207. doi:10.1099/jmm.0.042283-0.
  • Gao X, Wang Y, Shi L, Feng W, Yi K. Effect and safety of saccharomyces boulardii for neonatal necrotizing enterocolitis in pre-term infants: a systematic review and meta-analysis. J Trop Pediatr. 2021;67(3):fmaa022. doi:10.1093/tropej/fmaa022.
  • Boutin RCT, Sbihi H, McLaughlin RJ, Hahn AS, Konwar KM, Loo RS, Dai D, Petersen C, Brinkman FSL, Winsor GL, et al. Composition and associations of the infant gut fungal microbiota with environmental factors and childhood allergic outcomes. mBio. 2021;12(3):e0339620. doi:10.1128/mBio.03396-20.
  • Sanders ME, Benson A, Lebeer S, Merenstein DJ, Klaenhammer TR. Shared mechanisms among probiotic taxa: implications for general probiotic claims. Curr Opin Biotechnol. 2018;49:207–216. doi:10.1016/j.copbio.2017.09.007.
  • Yu Y, Lu J, Oliphant K, Gupta N, Claud K, Lu L, Aguila MB. Maternal administration of probiotics promotes gut development in mouse offsprings. PLoS One. 2020;15(8):e0237182. doi:10.1371/journal.pone.0237182.
  • Collado MC, González A, González R, Hernández M, Ferrús MA, Sanz Y. Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori. Int J Antimicrob Agents. 2005;25(5):385–391. doi:10.1016/j.ijantimicag.2005.01.017.
  • Marteau PR, de VM, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr. 2001;73(2):430s–436s. doi:10.1093/ajcn/73.2.430s.
  • Martino C, Dilmore AH, Burcham ZM, Metcalf JL, Jeste D, Knight R. Microbiota succession throughout life from the cradle to the grave. Nat Rev Microbiol. 2022;20(12):707–720. doi:10.1038/s41579-022-00768-z.
  • Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220–230. doi:10.1038/nature11550.
  • Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, Che T, Zhang C. Alteration of gut microbiota in Inflammatory Bowel Disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome. Pathogens. 2019;8(3):126. doi:10.3390/pathogens8030126.
  • Cenit MC, Olivares M, Codoñer-Franch P, Sanz Y. Intestinal microbiota and celiac disease: cause, consequence or co-evolution? Nutrients. 2015;7(8):6900–6923. doi:10.3390/nu7085314.
  • Campana R, van Hemert S, Baffone W. Strain-specific probiotic properties of lactic acid bacteria and their interference with human intestinal pathogens invasion. Gut Pathog. 2017;9(1):12. doi:10.1186/s13099-017-0162-4.
  • Shokryazdan P, Sieo CC, Kalavathy R, Liang JB, Alitheen NB, Faseleh Jahromi M, Ho YW. Probiotic potential of lactobacillus strains with antimicrobial activity against some human pathogenic strains. Biomed Res Int. 2014;2014:927268. doi:10.1155/2014/927268.
  • Turroni F, Milani C, Duranti S, Mahony J, van Sinderen D, Ventura M. Glycan utilization and cross-feeding activities by bifidobacteria. Trends Microbiol. 2018;26(4):339–350. doi:10.1016/j.tim.2017.10.001.
  • Chia LW, Mank M, Blijenberg B, Bongers RS, van Limpt K, Wopereis H, Tims S, Stahl B, Belzer C, Knol J. Cross-feeding between bifidobacterium infantis and anaerostipes caccae on lactose and human milk oligosaccharides. Benef Microbes. 2021;12(1):69–83. doi:10.3920/BM2020.0005.
  • Ma X, Fan X, P LL, Qiao SY, Zhang GL, Li DF. Butyrate promotes the recovering of intestinal wound healing through its positive effect on the tight junctions1. J Anim Sci. 2012;90(S4):266–268. doi:10.2527/jas.50965.
  • Peng L, Li Z-R, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-Activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009;139(9):1619–1625. doi:10.3945/jn.109.104638.
  • Henrick BM, Rodriguez L, Lakshmikanth T, Pou C, Henckel E, Arzoomand A, Olin A, Wang J, Mikes J, Tan Z, et al. Bifidobacteria-mediated immune system imprinting early in life. Cell. 2021;184(15):3884–3898.e11. doi:10.1016/j.cell.2021.05.030.
  • Morita N, Umemoto E, Fujita S, Hayashi A, Kikuta J, Kimura I, Haneda T, Imai T, Inoue A, Mimuro H, et al. GPR31-dependent dendrite protrusion of intestinal CX3CR1+ cells by bacterial metabolites. Nature. 2019;566(7742):110–114. doi:10.1038/s41586-019-0884-1.
  • Dong P, Yang Y, Wang W. The role of intestinal bifidobacteria on immune system development in young rats. Early Hum Dev. 2010;86(1):51–58. doi:10.1016/j.earlhumdev.2010.01.002.
  • Su GL, Ko CW, Bercik P, Falck-Ytter Y, Sultan S, Weizman AV, Morgan RL. AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology. 2020;159(2):697–705. doi:10.1053/j.gastro.2020.05.059.
  • Neu J. Routine probiotics for premature infants: let’s be careful! J Pediatr. 2011;158(4):672–674. doi:10.1016/j.jpeds.2010.11.028.
  • Mihatsch WA, Braegger CP, Decsi T, Kolacek S, Lanzinger H, Mayer B, Moreno LA, Pohlandt F, Puntis J, Shamir R, et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr. 2012;31(1):6–15. doi:10.1016/j.clnu.2011.09.004.
  • Courvalin P. Antibiotic resistance: the pros and cons of probiotics. Dig Liver Dis. 2006;38(2):S261–5. doi:10.1016/S1590-8658(07)60006-1.
  • Beattie LM, Hansen R, Barclay AR. Probiotics for preterm infants: confounding features warrant caution. Pediatrics. 2010;126(3):e742–743. . doi:10.1542/peds.2010-1949C.
  • Garland SM, Jacobs SE, Tobin JM, Opie GF, Donath S, ProPrems Study Group. A cautionary note on instituting probiotics into routine clinical care for premature infants. Pediatrics. 2010;126(3):e741–742. . doi:10.1542/peds.2010-1949B.
  • Chiang M-C, Chen C-L, Feng Y, Chen C-C, Lien R, Chiu C-H. Lactobacillus rhamnosus sepsis associated with probiotic therapy in an extremely preterm infant: pathogenesis and a review for clinicians. J Microbiol Immunol Infect. 2021;54(4):575–580. doi:10.1016/j.jmii.2020.03.029.
  • Esaiassen E, Cavanagh P, Hjerde E, Simonsen GS, Støen R, Klingenberg C. Bifidobacterium longum subspecies infantis bacteremia in 3 extremely preterm infants receiving probiotics. Emerg Infect Dis. 2016;22(9):1664–1666. doi:10.3201/eid2209.160033.
  • Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics. 2010;125(5):921–930. doi:10.1542/peds.2009-1301.
  • Aceti A, Maggio L, Beghetti I, Gori D, Barone G, Callegari ML, Fantini MP, Indrio F, Meneghin F, Morelli L, et al. Probiotics prevent late-onset sepsis in human milk-fed, very low birth weight preterm infants: systematic review and meta-analysis. Nutrients. 2017;9(8):904. doi:10.3390/nu9080904.
  • Samuels N, van de Graaf R, Been JV, de Jonge RCJ, Hanff LM, Wijnen RMH, Kornelisse RF, Reiss IKM, Vermeulen MJ. Necrotising enterocolitis and mortality in preterm infants after introduction of probiotics: a quasi-experimental study. Sci Rep. 2016;6(1):31643. doi:10.1038/srep31643.
  • Repa A, Thanhaeuser M, Endress D, Weber M, Kreissl A, Binder C, Berger A, Haiden N. Probiotics (Lactobacillus acidophilus and Bifidobacterium bifidum) prevent NEC in VLBW infants fed breast milk but not formula. Pediatr Res. 2015;77(2):381–388. doi:10.1038/pr.2014.192.
  • Wiciński M, Sawicka E, Gębalski J, Kubiak K, Malinowski B. Human milk oligosaccharides: health benefits, potential applications in infant formulas, and pharmacology. Nutrients. 2020;12(1):266. doi:10.3390/nu12010266.
  • Steenhout P, Sperisen P, Martin F-P, Sprenger N, Wernimont S, Pecquet S, Berger B. Term infant formula supplemented with human milk oligosaccharides (2′fucosyllactose and lacto-n-neotetraose) shifts stool microbiota and metabolic signatures closer to that of breastfed infants. FASEB J. 2016;30(S1):275.7–275.7. https://doi.org/10.1096/fasebj.30.1_supplement.275.7.
  • Su B-H. Optimizing nutrition in preterm infants. Pediatr Neonatol. 2014;55(1):5–13. doi:10.1016/j.pedneo.2013.07.003.
  • Kumar RK, Singhal A, Vaidya U, Banerjee S, Anwar F, Rao S. Optimizing nutrition in preterm low birth weight infants—consensus summary. Front Nutr. 2017;4:20. doi:10.3389/fnut.2017.00020.
  • Arslanoglu S, Boquien C-Y, King C, Lamireau D, Tonetto P, Barnett D, Bertino E, Gaya A, Gebauer C, Grovslien A, et al. Fortification of human milk for preterm infants: update and recommendations of the European milk bank association (EMBA) working group on human milk fortification. Front Pediatr. 2019;7:76. doi:10.3389/fped.2019.00076.
  • Quigley M, Embleton ND, McGuire W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev. 2019; 7 :CD002971. doi:10.1002/14651858.CD002971.pub5.
  • Kumbhare SV, Jones W-D, Fast S, Bonner C, Jong G’, Van DG, Graham M, Narvey M, MB A. Source of human milk (mother or donor) is more important than fortifier type (human or bovine) in shaping the preterm infant microbiome. Cell Rep Med. 2022;3(9):100712. doi:10.1016/j.xcrm.2022.100712.
  • Asbury MR, Shama S, Sa JY, Bando N, Butcher J, Comelli EM, Copeland JK, Forte V, Kiss A, Sherman PM, et al. Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants. Cell Host & Microbe. 2022;30(9):1328–1339.e5. doi:10.1016/j.chom.2022.07.011.
  • Arrieta M-C, Arévalo A, Stiemsma L, Dimitriu P, Chico ME, Loor S, Vaca M, Boutin RCT, Morien E, Jin M, et al. Associations between infant fungal and bacterial dysbiosis and childhood atopic wheeze in a nonindustrialized setting. J Allergy Clin Immunol. 2018;142(2):424–434.e10. doi:10.1016/j.jaci.2017.08.041.
  • Partida-Rodriguez O, Nieves-Ramirez M, Laforest-Lapointe I, Brown EM, Parfrey L, Valadez-Salazar A, Thorson L, Morán P, Gonzalez E, Rascon E, et al. Exposure to parasitic protists and helminths changes the intestinal community structure of bacterial communities in a cohort of mother-child binomials from a semirural setting in Mexico. mSphere. 2021;6(4):e00083–21. doi: 10.1128/mSphere.00083-21.
  • de Goffau MC, Jallow AT, Sanyang C, Prentice AM, Meagher N, Price DJ, Revill PA, Parkhill J, Pereira DIA, Wagner J. Gut microbiomes from Gambian infants reveal the development of a non-industrialized prevotella-based trophic network. Nat Microbiol. 2022;7(1):132–144. doi:10.1038/s41564-021-01023-6.
  • De Filippo C, Di Paola M, Ramazzotti M, Albanese D, Pieraccini G, Banci E, Miglietta F, Cavalieri D, Lionetti P. Diet, Environments, and Gut Microbiota. A preliminary investigation in children living in rural and urban Burkina Faso and Italy.Front Microbiol.2017;8: 1979. doi:10.3389/fmicb.2017.01979.
  • Deshpande G, Jape G, Rao S, Patole S. Benefits of probiotics in preterm neonates in low-income and medium-income countries: a systematic review of randomised controlled trials. BMJ Open. 2017;7(12):e017638. doi:10.1136/bmjopen-2017-017638.
  • Balasubramanian H, Ananthan A, Rao S, Patole S. Probiotics for preterm infants in India – systematic review and meta-analysis of randomized controlled trials. Indian J Pediatr. 2020;87(10):817–825. doi:10.1007/s12098-020-03223-0.
  • Panigrahi P, Parida S, Nanda NC, Satpathy R, Pradhan L, Chandel DS, Baccaglini L, Mohapatra A, Mohapatra SS, Misra PR, et al. A randomized synbiotic trial to prevent sepsis among infants in rural India. Nature. 2017;548(7668):407–412. doi:10.1038/nature23480.
  • Panigrahi P, Parida S, Pradhan L, Mohapatra SS, Misra PR, Johnson JA, Chaudhry R, Taylor S, Hansen NI, Gewolb IH. Long-term colonization of a lactobacillus plantarum synbiotic preparation in the neonatal gut. J Pediatr Gastroenterol Nutr. 2008;47(1):45–53. doi:10.1097/MPG.0b013e31815a5f2c.
  • Agarwal R, Sharma N, Chaudhry R, Deorari A, Paul VK, Gewolb IH, Panigrahi P. Effects of oral lactobacillus GG on enteric microflora in low-birth-weight neonates. J Pediatr Gastroenterol Nutr. 2003;36(3):397–402. doi:10.1097/00005176-200303000-00019.
  • Lewis ZT, Shani G, Masarweh CF, Popovic M, Frese SA, Sela DA, Underwood MA, Mills DA. Validating bifidobacterial species and subspecies identity in commercial probiotic products. Pediatr Res. 2016;79(3):445–452. doi:10.1038/pr.2015.244.
  • Kolaček S, Hojsak I, Berni Canani R, Guarino A, Indrio F, Orel R, Pot B, Shamir R, Szajewska H, Vandenplas Y, et al. Commercial Probiotic Products: a call for improved quality control. a position paper by the ESPGHAN working group for probiotics and prebiotics. J Pediatr Gastroenterol Nutr. 2017;65(1):117–124. doi:10.1097/MPG.0000000000001603.
  • Garland JS, Alex CP, Sevallius JM, Murphy DM, Good MJ, Volberding AM, Hofer LL, Gordon BJ, Maki DG. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infect Control Hosp Epidemiol. 2008;29(3):243–249. doi:10.1086/526439.
  • Feja KN, Wu F, Roberts K, Loughrey M, Nesin M, Larson E, Della-Latta P, Haas J, Cimiotti J, Saiman L. Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr. 2005;147(2):156–161. doi:10.1016/j.jpeds.2005.02.021.
  • Bizzarro MJ, Peaper DR, Morotti RA, Paci G, Rychalsky M, Boyce JM. Gastrointestinal zygomycosis in a preterm neonate associated with contaminated probiotics. Pediatr Infect Dis J. 2021;40(4):365–367. doi:10.1097/INF.0000000000003063.